Welcome to the Primary Care and Nursing Staff Hub, a dedicated educational resource exploring the role of primary care and nursing professionals in supporting people with Alzheimer's disease who are considering or receiving anti-amyloid therapies.
Amyloid-related imaging abnormalities (ARIA) present important considerations for treatment eligibility, patient counselling and ongoing monitoring. Understanding individual risk factors, recognising potential concerns and communicating effectively with patients and their families are essential to delivering coordinated, patient-centred care.
Explore the educational resources below, including an expert-led video and an interactive multimedia snapshot, to strengthen your understanding of ARIA and support shared decision-making across the care pathway.
This activity has been supported by an independent education grant from Lilly. This education program is only available to healthcare professionals globally, excluding the United Kingdom.
